1st Qtrly 16-17 2nd Qtrly 16-17 3rd Qtrly 16-17 4th Qtrly 16-17 30TH ANNUAL REPORT 2015-2016
1st Qtrly 15-16 2nd Qtrly 15-16 3rd Qtrly 15-16 4th Qtrly 15-16 29TH ANNUAL REPORT 2014-2015
1st Qtrly 14-15 2nd Qtrly 14-15 3rd Qtrly 14-15 4th Qtrly 14-15 28TH ANNUAL REPORT 2013-2014
1st Qtrly 13-14 2nd Qtrly 13-14 3rd Qtrly 13-14 4th Qtrly 13-14 27TH ANNUAL REPORT 2012-2013
1st Qtrly 12-13 2nd Qtrly 12-13 3rd Qtrly 12-13 4th Qtrly 12-13 26TH ANNUAL REPORT 2011-2012
1st Qtrly 11-12 2nd Qtrly 11-12 3rd Qtrly 11-12 4th Qtrly 11-12 25TH ANNUAL REPORT 2010-2011

COLINZ LABORATORIES LIMITED
A-101, Pratik Ind. Estate, Next to Fortis Hospital, Mulund-Goregaon Link Road, Mumbai - 400 078.

UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2012

  (Rupees in '000')
S. No. Particulars Un -audited Audited
Quarter Ended Year Ended
30.06.2012 31.03.2012 30.06.2011 31.03.2012
PART - I          
1 (a) Income from Operation        
    Gross Sales 23,253 13,225 21,972 70,455
    Less: Excise Duty 1,547 1,509 797 4,435
      Net Sales 21,706 11,716 21,175 66,020
  (b) Other Operating  Income  - - - -
  Total Income from Operation 21,706 11,716 21,175 66,020
2 Expenditure - - - -
  (a) Consumption of Materials 5,984 6,761 6,237 24,418
  (b) Purchase of Goods Traded 1,870 937 688 3,457
  (c) (Increase)/Decrease in stock in trade 2,389 -5,021 4,426 -1,095
  (d) Staff Cost 6,881 4,610 5,442 22,545
  (e) Depreciation 653 666 644 2,599
  (f) Other Expenditure 3,112 3,292 3,038 11,694
  Total Expenditure 20,889 11,245 20,475 63,618
3 Profit /Loss from Operation Before Other Income (1-2) 817 471 700 2,402
4 Other  Income /(Loss) 206 159 29 369
5 Profit /Loss before Interest & Exceptional items (3+4) 1,023 630 729 2,771
6 Interest 537 569 410 1,893
7 Profit /Loss  after Interest but before exceptional items (5-6) 486 61 319 878
8 Exceptional items  - - - -
9 Profit /Loss before Tax (7-8) 486 61 319 878
10 Tax Expenses (Provision for Taxation):      Current tax - - - 158
                                                                Deffered tax - - - -384
             
11 Net Profit/Loss  after Tax (9-10) 486 61 319 1,104
12 Paid up Equity Share Capital (Face Value 10/- Per Share) 354,35 354,35 354,35 354,35
[Net of allotment money in arrears]    
13 Reserves Excluding Revaluation Reserves  - - - 7,630
14 Earning per share (EPS) before extraordinary item (not Annualised) - - - -
  Basic & Diluted - - - 0.24
             
PART-II A. PARTICULARS  OF SHAREHOLDING         
1 Public Shareholding         
  i) Number of Shares 29,04,900 29,02,900 29,02,900 29,02,900
  ii) Percentage of shareholding  63.55% 63.51% 63.51% 63.51%
2 Promoters and promoter group Shareholding         
a) Pledged/Encumbered        
i) Number of shares - - - -
  ii) Percentage of shares (as a % of the total shareholding of - - - -
  promoter and promoter group)        
  iii) Percentage of shares (as a% of the total share capital of the company) - - - -
  b) Non-encumbered        
i) Number of Shares 16,66,100 1668100 1668100 1668100
  ii) Percentage of shares (as a% of the total shareholding) 36.45% 36.49% 36.49% 36.49%
   of promoter and promoter group)        
  iii) Percentage of shares (as a % of the total share capital of the company) 100% 100% 100% 100%

 

  B. INVESTORS COMPLAINTS 3 Months ended 30.06.12
  Pending at Begining of the Quarter  NIL
  Received During the Quarter NIL
  Disposed of During the Quarter NIL
  Remaining at the end of the Quarter NIL

 

NOTES :-
  1. The above financial results have been taken on record at a meeting of Board of Directors held on  31.07.2012
  2. The Company operates in single segment of manufacture of pharmaceutical formulations. Hence Accounting Standard on segment reporting is not applicable.
  3. Previous period figures have been regrouped wherever required.

 

  For and on behalf of the Board
  COLINZ LABORATORIES LIMITED
   
Mumbai Dr. L. S. Mani
31.07.2012 Chairman & Managing Director.

                                                                                                                     

(Top)

Contact:
A/101, Pratik Estate,
Mulund Link Road,
Next to Fortis Hospital,
Mumbai-400078.
Tel.: 91-22-25668002/3
Fax: 91-22-25668006.
Email: cllfindoc@yahoo.com
Website:www.findoc-cll.in
Email:info@findoc-cll.in